This inventor holds 5 USPTO granted patents. Top assignee: Sandoz Gmbh. Active years: 1977-1988.
Location History:
- Arlesheim, CH (1977 - 1979)
- Oberwil, CH (1981 - 1988)
Company Filing History:
Years Active: 1977-1988
Title: Paul Pfaffli: Innovator in Pharmaceutical Chemistry
Introduction
Paul Pfaffli is a notable inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 5 patents to his name, Pfaffli's work has garnered attention in the scientific community.
Latest Patents
Among his latest patents, Pfaffli has developed N,N-diethyl-N'-[(8.alpha.)-1-ethyl-6-methyl-ergolin-8-yl]-sulfamide. This invention provides a compound that is useful for inhibiting prolactin secretion and serves as an anti-Parkinson and anti-depressant agent. Additionally, he has worked on organic compounds, specifically decahydro or octahydro-4-phenyl-cis-isoquinoline derivatives, which are recognized for their potential as analgesics, anti-depressants, tranquilizers, and sleep inducers.
Career Highlights
Paul Pfaffli is currently employed at Sandoz GmbH, a leading global healthcare company. His work at Sandoz has allowed him to focus on innovative solutions in the pharmaceutical industry, contributing to the development of new therapeutic agents.
Collaborations
Pfaffli collaborates with Hartmut Hauth, a fellow researcher, to advance their work in pharmaceutical innovations. Their partnership has been instrumental in the successful development of various compounds.
Conclusion
In summary, Paul Pfaffli is a distinguished inventor whose contributions to pharmaceutical chemistry have led to the development of important therapeutic agents. His innovative work continues to impact the field positively.